United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Technology Industry News Startek goes private with Capital Square Partners’ acquisition for $4.3 per share Startek, Inc. (NYSE: SRT), a renowned global customer experience (CX) solutions provider, announced the completion of its acquisition… byPallavi MadhirajuJanuary 7, 2024